Spravato (Esketamine) Near Syracuse, NY

Spravato for treatment-resistant depression

CNY Psychiatry provides Spravato care in Marcellus for patients from Syracuse, Onondaga County and Central New York. Spravato is a prescription nasal spray containing esketamine. It is FDA-approved for adults with treatment-resistant depression, either on its own or with an oral antidepressant.

A psychiatric consultation reviews your diagnosis, previous treatment and response, current symptoms, health considerations and goals. Treatment resistance does not automatically mean Spravato is the right next step. Our team considers it within a broader psychiatric care plan.

What a Spravato session looks like

Treatment takes place in an office certified through the Spravato Risk Evaluation and Mitigation Strategy (REMS). You self-administer the nasal spray under healthcare-provider supervision and remain under observation for at least two hours after each dose. The team monitors safety and determines when you are ready to leave.

Each Spravato treatment at CNY Psychiatry includes psychiatric assessment. Your clinician reviews how you are doing and whether the treatment plan remains appropriate. Plan enough time for assessment, treatment, monitoring and recovery.

Transportation after treatment

Patients cannot drive themselves home after a Spravato treatment. Arrange for a caregiver or family member to drive you home. Do not drive or operate machinery until the next day after a restful sleep.

Your Spravato care team

Dr. Jason Stepkovitch, MD, the founder and Medical Director of CNY Psychiatry, provides specialty consultations for patients considering Spravato. Lindsay Szlamczynski, NP, is dedicated to the practice's ketamine and Spravato programs. Ask the office about current clinician availability and your visit arrangements.

Insurance and prior authorization

Spravato is often covered by insurance when a plan's eligibility and medical-necessity criteria are met. Prior authorization is usually required. Our team can review your benefits and authorization requirements, but coverage, approval and out-of-pocket costs vary by plan and are not guaranteed.

Spravato and IV ketamine are different treatments with different payment arrangements. At CNY Psychiatry, IV ketamine is self-pay and is not covered by insurance. A consultation can help you compare the clinical options as well as practical considerations.

Safety and next steps

Spravato may affect alertness, perception, breathing and blood pressure. The clinician reviews suitability, risks and required monitoring before treatment. Spravato is not a proven suicide-prevention treatment and does not replace hospitalization when it is needed. If you are in crisis, call or text 988.

Explore the related treatment and FAQ pages below, or request a consultation to discuss whether esketamine fits your needs. You do not need to choose a treatment before contacting us.